User profiles for Kiyoshi Mori
Kiyoshi MoriShizuoka Graduate University of Public Health Verified email at s-sph.ac.jp Cited by 25066 |
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
…, C Kelly, SM Ruff, K Zahedi, M Shao, J Bean, K Mori… - The Lancet, 2005 - thelancet.com
Background The scarcity of early biomarkers for acute renal failure has hindered our ability
to launch preventive and therapeutic measures for this disorder in a timely manner. We …
to launch preventive and therapeutic measures for this disorder in a timely manner. We …
[HTML][HTML] Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
…, A Yokoyama, M Fukuoka, K Mori… - … England Journal of …, 2002 - Mass Medical Soc
Background Irinotecan hydrochloride, a topoisomerase I inhibitor, is effective against small-cell
lung cancer. In a phase 2 study of irinotecan plus cisplatin in patients with extensive small…
lung cancer. In a phase 2 study of irinotecan plus cisplatin in patients with extensive small…
[HTML][HTML] Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury
K Mori, HT Lee, D Rapoport, IR Drexler… - The Journal of …, 2005 - Am Soc Clin Investig
Neutrophil gelatinase–associated lipocalin (Ngal), also known as siderocalin, forms a
complex with iron-binding siderophores (Ngal: siderophore: Fe). This complex converts renal …
complex with iron-binding siderophores (Ngal: siderophore: Fe). This complex converts renal …
Ghrelin strongly stimulates growth hormone release in humans
…, A Yoshimoto, M Harada, K Mori… - The journal of …, 2000 - academic.oup.com
Ghrelin is a recently identified endogenous ligand for the GH secretagogue receptor and is
involved in a novel system for regulating GH release. However, little is known about its GH-…
involved in a novel system for regulating GH release. However, little is known about its GH-…
Dual action of neutrophil gelatinase–associated lipocalin
KM Schmidt-Ott, K Mori, JY Li… - Journal of the …, 2007 - journals.lww.com
Neutrophil gelatinase–associated lipocalin (NGAL) is expressed and secreted by immune
cells, hepatocytes, and renal tubular cells in various pathologic states. NGAL exerts …
cells, hepatocytes, and renal tubular cells in various pathologic states. NGAL exerts …
Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase–associated lipocalin for diagnosing acute kidney injury
Background: A single serum creatinine measurement cannot distinguish acute kidney injury
from chronic kidney disease or prerenal azotemia. Objective: To test the sensitivity and …
from chronic kidney disease or prerenal azotemia. Objective: To test the sensitivity and …
[PDF][PDF] An iron delivery pathway mediated by a lipocalin
Despite the critical need for iron in many cellular reactions, deletion of the transferrin pathway
does not block organogenesis, suggesting the presence of alternative methods to deliver …
does not block organogenesis, suggesting the presence of alternative methods to deliver …
Association between increases in urinary neutrophil gelatinase–associated lipocalin and acute renal dysfunction after adult cardiac surgery
Background Acute renal dysfunction (ARD) and subsequent acute renal failure after cardiac
surgery are associated with high mortality and morbidity. Early therapeutic or preventive …
surgery are associated with high mortality and morbidity. Early therapeutic or preventive …
Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin
J Mishra, K Mori, Q Ma, C Kelly, J Yang… - Journal of the …, 2004 - journals.lww.com
Acute renal failure secondary to ischemic injury remains a common problem, with limited and
unsatisfactory therapeutic options. Neutrophil gelatinase-associated lipocalin (NGAL) was …
unsatisfactory therapeutic options. Neutrophil gelatinase-associated lipocalin (NGAL) was …
Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity
J Mishra, K Mori, Q Ma, C Kelly, J Barasch… - American journal of …, 2004 - karger.com
Background: Cisplatin is one of the most widely used chemotherapeutic agents, but the risk
of nephrotoxicity frequently hinders the use of higher doses to maximize its antineoplastic …
of nephrotoxicity frequently hinders the use of higher doses to maximize its antineoplastic …